Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial.

Gland surgery·2026
Same author

A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer.

Clinical breast cancer·2026
Same author

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

Nature cancer·2026
Same author

IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer.

JCI insight·2026
Same author

ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.

Annals of surgical oncology·2026
Same author

Immune-driven stromal inflammation in pancreatic cancer within a microfluidic platform.

Biofabrication·2026

Related Experiment Video

Updated: Apr 19, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.4K

Optimizing dendritic cell-based approaches for cancer immunotherapy.

Jashodeep Datta1, Julia H Terhune2, Lea Lowenfeld1

  • 1Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

The Yale Journal of Biology and Medicine
|December 16, 2014
PubMed
Summary

Dendritic cell (DC) immunotherapy shows promise for cancer treatment by stimulating immune responses. Further research into DC immunobiology and combination therapies may lead to more effective cancer vaccines.

Keywords:
cancerchemotherapycombination therapydendritic cellimmunotherapyvaccine

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.4K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

Area of Science:

  • Immunology
  • Cancer Research
  • Vaccine Development

Background:

  • Dendritic cells (DCs) are key antigen-presenting cells crucial for initiating and regulating immune responses.
  • DCs play a vital role in bridging innate and adaptive immunity, making them attractive candidates for cancer immunotherapy.
  • Current DC-based cancer immunotherapy strategies show promise but yield inconsistent clinical results, highlighting the need for optimization.

Purpose of the Study:

  • To explore the immunobiology of dendritic cells (DCs) for optimizing cancer immunotherapy.
  • To review current strategies in DC-based vaccine design and identify areas for improvement.
  • To discuss the potential of next-generation DC vaccines and multimodality approaches in cancer treatment.

Main Methods:

  • Review of current literature on dendritic cell (DC) immunobiology and vaccine design.
  • Analysis of cytokine activation regimens, DC maturation states, and antigen-loading strategies.
  • Evaluation of clinical outcomes from existing DC-based cancer immunotherapy trials.

Main Results:

  • Dendritic cells (DCs) are potent inducers of primary immune responses and enhancers of T-cell effector functions.
  • Despite advancements like sipuleucel-T approval, DC immunotherapy as a monotherapy for most cancers remains a challenge.
  • Diverse approaches in DC vaccine design reflect an incomplete understanding of optimal DC function.

Conclusions:

  • Optimizing dendritic cell (DC) immunobiology is critical for enhancing cancer immunotherapy efficacy.
  • Next-generation DC vaccines and combination therapies hold significant potential for improving clinical outcomes in cancer treatment.
  • Further research is needed to overcome current limitations and achieve more consistent and potent DC-based cancer immunotherapy.